Yee Anita, Tsui Nancy B Y, Kwan Rick Y C, Leung Angela Y M, Lai Claudia K Y, Chung Teresa, Lau Johnson Y N, Fok Manson, Dai David L K, Lau Lok-Ting
Avalon Genomics (Hong Kong) Limited, Shatin,Hong Kong.
Centre for Gerontological Nursing, School of Nursing, The Hong Kong Polytechnic University, Hung Hom,Hong Kong.
Curr Alzheimer Res. 2021;18(1):67-79. doi: 10.2174/1567205018666210324111401.
APOE ε4 is the best-known risk factor for late-onset alzheimer's disease (AD). Population studies have demonstrated a relatively low prevalence of APOE ε4 among Chinese population, implying additional risk factors that are Chinese-specific may exist. Apart from - alleles, genetic variation profile along the full-length APOE has rarely been investigated.
In this study, we filled this gap by comprehensively determining all genetic variations in APOE and investigated their potential associations with late-onset AD and mild cognitive impairment (MCI) in southern Chinese.
Two hundred and fifty-seven southern Chinese participants were recruited, of whom 69 were AD patients, 83 had MCI, and 105 were normal controls. Full-length APOE from promoter to 3'UTR regions were sequenced. Genetic variants were identified and compared among the three groups.
While APOE ε4 was more significantly found in AD patients, the prevalence of APOE ε4 in southern Chinese AD patients was the lowest when compared to other areas of China and nearby regions, as well as other countries worldwide. We further identified 13 rare non-singleton variants in APOE. Significantly more AD patients carried any of the rare non-singleton variants than MCI and normal subjects. Such difference was observed in the non-carriers of ε4-allele only. Among the identified rare variants, the potential functional impact was predicted for rs532314089, rs553874843, rs533904656 and rs370594287.
Our study suggests an ethnic difference in genetic risk composition of AD in southern Chinese. Rare variants on APOE are a potential candidate for AD risk stratification biomarker in addition to APOE-ε4.
APOE ε4是晚发型阿尔茨海默病(AD)最著名的风险因素。人群研究表明,中国人群中APOE ε4的患病率相对较低,这意味着可能存在特定于中国人群的其他风险因素。除了-等位基因外,很少有人研究APOE全长的基因变异情况。
在本研究中,我们通过全面确定APOE中的所有基因变异来填补这一空白,并研究它们与中国南方晚发型AD和轻度认知障碍(MCI)的潜在关联。
招募了257名中国南方参与者,其中69名是AD患者,83名患有MCI,105名是正常对照。对从启动子到3'UTR区域的APOE全长进行测序。鉴定基因变异并在三组之间进行比较。
虽然在AD患者中更显著地发现了APOE ε4,但与中国其他地区、附近地区以及世界其他国家相比,中国南方AD患者中APOE ε4的患病率是最低的。我们进一步在APOE中鉴定出13种罕见的非单例变异。携带任何一种罕见非单例变异的AD患者明显多于MCI患者和正常受试者。仅在ε4等位基因非携带者中观察到这种差异。在鉴定出的罕见变异中,预测了rs532314089、rs553874843、rs533904656和rs370594287的潜在功能影响。
我们的研究表明中国南方AD的遗传风险构成存在种族差异。除了APOE-ε4外,APOE上的罕见变异是AD风险分层生物标志物的潜在候选者。